BridgeBio Pharma

BBIO

Market cap $13.8B

Upgrade to unlock

Buy

Hold

Sell

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$89

24% upside

High target

10 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Wells Fargo Derek Archila 100% 1-yr BBIO win rate				11 Nov ‘25 21 days ago
JP Morgan Anupam Rama 100% 1-yr BBIO win rate				7 Nov ‘25 24 days ago
HC Wainwright & Co Raghuram Selvaraju 80% 1-yr BBIO win rate				3 Nov ‘25 29 days ago
Goldman Sachs Paul Choi 100% 1-yr BBIO win rate				31 Oct ‘25 1 month ago
TD Cowen Tyler Van Buren 100% 1-yr BBIO win rate				30 Oct ‘25 1 month ago
Raymond James Martin Auster 100% 1-yr BBIO win rate				30 Oct ‘25 1 month ago
Cantor Fitzgerald Josh Schimmer 100% 1-yr BBIO win rate				30 Oct ‘25 1 month ago
Piper Sandler Biren Amin 100% 1-yr BBIO win rate				30 Oct ‘25 1 month ago
Truist Securities Danielle Brill 100% 1-yr BBIO win rate				30 Oct ‘25 1 month ago
UBS Eliana Merle 100% 1-yr BBIO win rate				12 Sep ‘25 2 months ago